Search Results for ""

WRadio: La vacuna Janssen tiene una sola dosis: infectólogo

Dr. Jose Cadena Zuluaga, Infectious Diseases, spoke on a Colombia radio program regarding the advantages of Johnson & Johnson’s Janssen vaccine arriving in Colombia. The advantages include that it has only one dose and does not require refrigeration as the other vaccines. Listen here. 

Read more

Texas Public Radio: New vaccine alleged to have 100% efficacy against original COVID-19 strain

This Texas Public Radio news brief is about the biotechnology company Novavax releasing Phase 3 clinical trial results. UT Health San Antonio collaborated with University Health as part of the international COVID-19 Prevention Network and enrolled 176 Novavax clinical trial participants in San Antonio for the Phase 3 study, which is called PREVENT-19. Read the story.

Read more

San Antonio Business Journal: Alamo City research contributes to potential new COVID vaccine

Dr. Barbara Taylor, Infectious Diseases, and the great work of the Novavax research team of UT Health San Antonio and University Health, are featured in the San Antonio Business Journal. The local site of the international clinical trial by the COVID-19 Prevention Network enrolled more than 175 participants. Read the story.

Read more

KSAT 12: COVID-19 vaccine can be taken at same time, within 14 days of other vaccines, CDC says

Dr. Ruth Berggren, Infectious Diseases/Center for Medical Humanities & Ethics, spoke to KSAT 12 TV audiences on the topic that the COVID-19 vaccine can be taken at the same time as other vaccines, according to the CDC. Watch the story.

Read more

Voelcker Fund supports cancer research and discovery at UT Health San Antonio

Microscope in laboratory

The Max and Minnie Tomerlin Voelcker Fund is awarding $800,000 to UT Health San Antonio to support research projects conducted by promising early career researchers.

Read more

Novavax vaccine is highly protective against COVID-19 in Phase 3 results

Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu Elizabeth Allen, 210-358-2344, elizabeth.allen@uhs-sa.com SAN ANTONIO (June 14, 2021) — Researchers at UT Health San Antonio are buoyed by today’s news that the Novavax vaccine is strongly effective against the COVID-19 virus. Biotechnology company Novavax released Phase 3 clinical trial results from 119 sites in the U.S. and Mexico this […]

Read more